CopyFind
Hepabert Tablet

Hepabert Tablet

180,00 ₹

Analogs of Hepabert Tablet

Find cheaper analogs and generic equivalents for Hepabert Tablet.

Ingredients

सक्रिय अवयव: silymarin


उत्पाद अवलोकन

About Hepabert Tablet

Hepabert Tablet is a pharmaceutical product formulated to support liver health. This medicine is designed for oral administration and is typically prescribed by healthcare professionals to manage specific hepatic conditions. By combining two distinct active components, the tablet works to assist in the maintenance of normal liver function. Patients should always follow the specific dosage instructions provided by their physician to ensure the safe and effective use of this medication. It is essential to store this product in a cool, dry place away from direct sunlight and out of the reach of children.

Key Benefits & Uses

  • Supports the maintenance of healthy liver function.
  • Utilizes a dual-action formula for comprehensive hepatic support.
  • Provides a convenient oral dosage form for consistent therapeutic management.

Active Ingredient & Action

Hepabert Tablet contains two primary active ingredients: L-Ornithine L-Aspartate and Silymarin. L-Ornithine L-Aspartate is known for its role in ammonia detoxification processes within the body. Silymarin, a standardized extract derived from milk thistle, is widely recognized for its antioxidant properties and its traditional use in supporting liver cell integrity. Together, these components aim to provide a balanced approach to liver care.

Important Notes

This medicine should only be used under the direct supervision of a qualified medical practitioner. Do not exceed the recommended daily dose. If you experience any adverse reactions or have underlying health conditions, consult your doctor immediately before continuing use. Always check the expiration date on the packaging before consumption.

Find in Pharmacies

Compare local prices and distance for Hepabert Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.